KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Palvella Therapeutics (PVLA) Asset Utilization Ratio (2016 - 2024)

Palvella Therapeutics has reported Asset Utilization Ratio over the past 9 years, most recently at 0.19 for Q3 2022.

  • Quarterly Asset Utilization Ratio rose 36.26% to 0.19 in Q3 2022 from the year-ago period, while the trailing twelve-month figure was 0.19 through Sep 2022, up 36.26% year-over-year, with the annual reading at 0.24 for FY2021, 25.06% up from the prior year.
  • Asset Utilization Ratio was 0.19 for Q3 2022 at Palvella Therapeutics, down from 0.19 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 0.43 in Q2 2020 and troughed at 0.14 in Q3 2021.
  • The 5-year median for Asset Utilization Ratio is 0.21 (2019), against an average of 0.24.
  • Year-over-year, Asset Utilization Ratio skyrocketed 183.02% in 2018 and then crashed 65.4% in 2021.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.17 in 2018, then surged by 112.15% to 0.36 in 2019, then plummeted by 38.85% to 0.22 in 2020, then decreased by 17.46% to 0.18 in 2021, then increased by 3.0% to 0.19 in 2022.
  • Per Business Quant, the three most recent readings for PVLA's Asset Utilization Ratio are 0.19 (Q3 2022), 0.19 (Q2 2022), and 0.18 (Q1 2022).